Benign Prostatic Hyperplasia Clinical Trials 2023

Browse 13 Benign Prostatic Hyperplasia Medical Studies Across 33 Cities

34 Benign Prostatic Hyperplasia Clinics

Clinical TrialsBenign Prostatic Hyperplasia Clinical Trials 2023
Reviewed by Michael Gill, B. Sc.
Image of Charles White, MD in Mobile, United States.

Treatmentfor Benign Prostatic Hyperplasia

45 - 80
Male
Mobile, AL
Patients who are currently symptomatic and have been diagnosed with BPH by a physician may qualify for this 20-week study. Patients must not be diabetic, must not have prostate cancer and must not have had any surgery to repair your prostate or treat your BPH. Patients will first undergo a phone screening to confirm their eligibility and interest and to rule out any exclusionary history or medications. Eligible patients will be scheduled to come in to the clinic to sign an Informed Consent Form. Patients will then undergo blood and urine tests, a complete physical examination and history and answer several questionnaires to determine their eligibility. Patients will have a total of at least 7-8 visits over 20 weeks to the clinic during this study.Qualified patients receive free study medication, free medical care (physical examinations, EKG, laboratory tests) for the duration of the study.
Phase 2
Waitlist Available
Charles White, MD (+13 Sites)Milkhaus Laboratory
10 Benign Prostatic Hyperplasia Clinical Trials Near Me
Top Hospitals for Benign Prostatic Hyperplasia Clinical Trials
Image of University Hospitals Cleveland Medical Center in Ohio.
University Hospitals Cleveland Medical Center
Cleveland
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
Image of UH Brainard Medical Bldg in Ohio.
UH Brainard Medical Bldg
Lyndhurst
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
Image of UH Regional Hospitals - Richmond Campus in Ohio.
UH Regional Hospitals - Richmond Campus
Richmond Heights
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
Image of Thunder Bay Regional Health Sciences Centre in Ontario.
Thunder Bay Regional Health Sciences Centre
Thunder Bay
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2022First Benign Prostatic Hyperplasia Trial
Image of Urology Specialist Group in Florida.
Urology Specialist Group
Hialeah
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2020First Benign Prostatic Hyperplasia Trial
Top Cities for Benign Prostatic Hyperplasia Clinical Trials
Image of Thunder Bay in Ontario.
Thunder Bay
2Active Trials
Thunder Bay Regional Health Sciences CentreTop Active Site
Image of Cleveland in Ohio.
Cleveland
1Active Trials
University Hospitals Cleveland Medical CenterTop Active Site
Benign Prostatic Hyperplasia Clinical Trials by Phase of Trial
N/A Benign Prostatic Hyperplasia Clinical Trials
7Active Benign Prostatic Hyperplasia Clinical Trials
6Number of Unique Treatments
5Number of Active Locations
Thulium Fibre LaserProstatic Artery Embolization (HydroPearl® compressible microspheres)Top-Down HoLEPEmbozene MicrospheresProstate Artery EmbolizationProstate Artery EmbolizationProstate Arterial Embolization
Benign Prostatic Hyperplasia Clinical Trials by Age Group
18+ Benign Prostatic Hyperplasia Clinical Trials
13Active Benign Prostatic Hyperplasia Clinical Trials
Intravesical Botox injectionThulium Fibre LaserSoracteLite(TM) TPLA for BPHProstatic Artery Embolization (HydroPearl® compressible microspheres)Top-Down HoLEPEmbozene MicrospheresProstate Artery EmbolizationProstate Artery Embolization
Most Recent Benign Prostatic Hyperplasia Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Treatment Group for Overactive Bladder
12/1/2021
Phase 4
SoracteLite(TM) TPLA for BPH for Prostate Disease
11/20/2020
Phase 1
Treatment for Enlarged Prostate
5/1/2008
Phase 4
Prolieve for Enlarged Prostate
2/1/2006
Phase 4
Treatment for Benign Prostatic Hyperplasia
4/1/2002
Phase 2
Top Treatments for Benign Prostatic Hyperplasia Clinical Trials
Treatment Name
Active Benign Prostatic Hyperplasia Clinical Trials
All Time Trials for Benign Prostatic Hyperplasia
First Recorded Benign Prostatic Hyperplasia Trial
Prostate Artery Embolization
2
5
2014
Treatment
2
2
2002
Intravesical Botox injection
1
1
2023
Thulium Fibre Laser
1
1
2022
SoracteLite(TM) TPLA for BPH
1
1
2020
Recently Completed Studies with FDA Approved Treatments for Benign Prostatic Hyperplasia
Treatment
Year
Sponsor
Vibegron
2019
Urovant Sciences GmbH
Vibegron
2019
Urovant Sciences GmbH

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: September 8th, 2023

References1 Olweny EO, Jow SL, Jow WW. Prolieve Transurethral Thermodilatation for treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multicenter Trial. J Endourol. 2021 Nov 1. doi: 10.1089/end.2021.0240. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/343142412 Allameh F, Basiri A, Razzaghi M, Abedi AR, Fallah-Karkan M, Ghiasy S, Hosseininia SM, Montazeri S. Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin - A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case-Control Study. Clin Pharmacol. 2020 Jun 26;12:75-81. doi: 10.2147/CPAA.S256051. eCollection 2020. https://pubmed.ncbi.nlm.nih.gov/326170233 Antunes AA, Srougi M, Coelho RF, de Campos Freire G. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol. 2007 Mar;4(3):155-60. doi: 10.1038/ncpuro0735. https://pubmed.ncbi.nlm.nih.gov/173476604 Olweny EO, Jow SL, Jow WW. Prolieve Transurethral Thermodilatation for Treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multicenter Trial. J Endourol. 2022 Jan;36(1):117-123. doi: 10.1089/end.2021.0240. Epub 2021 Nov 1. https://pubmed.ncbi.nlm.nih.gov/343142415 Fusco F, Creta M, De Nunzio C, Iacovelli V, Mangiapia F, Li Marzi V, Finazzi Agrò E. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018 Mar 9;18(1):15. doi: 10.1186/s12894-018-0329-4. Review. https://pubmed.ncbi.nlm.nih.gov/295192366 Ahyai SA, Marik I, Ludwig TA, Becker A, Asdjodi S, Kluth L, Chun F, Fisch M, Schmid M. Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study. World J Urol. 2020 Dec;38(12):3207-3217. doi: 10.1007/s00345-020-03126-x. Epub 2020 Feb 21. https://pubmed.ncbi.nlm.nih.gov/320865717 Rapp DE, Lucioni A, Bales GT. Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol. 2007 Mar-Apr;33(2):132-41. doi: 10.1590/s1677-55382007000200002. https://pubmed.ncbi.nlm.nih.gov/174885318 Rapp DE, Lucioni A, Bales GT. Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol. 2007 Mar-Apr;33(2):132-41. Review. https://pubmed.ncbi.nlm.nih.gov/174885319 Fusco F, Creta M, De Nunzio C, Iacovelli V, Mangiapia F, Li Marzi V, Finazzi Agro E. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018 Mar 9;18(1):15. doi: 10.1186/s12894-018-0329-4. https://pubmed.ncbi.nlm.nih.gov/2951923610 Antunes AA, Srougi M, Coelho RF, de Campos Freire G. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol. 2007 Mar;4(3):155-60. Review. https://pubmed.ncbi.nlm.nih.gov/17347660
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top